Lv4
630 积分 2021-08-09 加入
Efficacy, Safety, and Tolerability of Efgartigimod in Patients with Chronic Inflammatory Demyelinating Polyneuropathy: Results from the ADHERE Trial (PL5.002)
3个月前
已完结
The expanding field of IgG4‐mediated neurological autoimmune disorders
3个月前
已完结
Landscape of cancer cell therapies: trends and real-world data
4个月前
已完结
A decade of innovation in pharmaceutical R&D: the Chorus model
5个月前
已完结
Associations between alcohol consumption and gray and white matter volumes in the UK Biobank
5个月前
已完结
Dihydroergotoxine mesylate for the treatment of sialorrhea in Parkinson's disease
6个月前
已完结
LEONARDA-1: Phase III randomized study of lerociclib plus fulvestrant in patients with HR+, HER2- locally advanced or metastatic breast cancer that has progressed on prior endocrine therapy
7个月前
已完结
The Contract Research Organization and the Commercialization of Scientific Research
10个月前
已完结
Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement
1年前
已完结
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
1年前
已完结
皖公网安备34019202002308
